InvestorsHub Logo
Followers 1080
Posts 106268
Boards Moderated 55
Alias Born 11/22/2003

Re: None

Tuesday, 04/14/2009 11:10:03 AM

Tuesday, April 14, 2009 11:10:03 AM

Post# of 23
Abraxis BioScience (Nasdaq: ABBI) is developing drugs based on
its nab (nanoparticle-albumin bound) technology.
Essentially, the company takes chemotherapy drugs and surrounds
them with albumin protein.
Since albumin is used by tumor cells as a way to bring in
nutrients, the tumor cells take up the albumin-bound drug
more readily than they would a similar drug without albumin.
The shell also increases the solubility of the drug, making
it easier to deliver it to wherever it's needed in the body.

http://www.fool.com/investing/high-growth/2007/09/26/4-platform-drugmakers-to-watch.aspx